National Health Investors, Inc. (NYSE:NHI - Free Report) - Investment analysts at Wedbush issued their Q1 2026 earnings per share estimates for shares of National Health Investors in a report issued on Monday, March 17th. Wedbush analyst R. Anderson forecasts that the real estate investment trust will post earnings per share of $1.20 for the quarter. Wedbush has a "Outperform" rating and a $88.00 price objective on the stock. The consensus estimate for National Health Investors' current full-year earnings is $4.41 per share. Wedbush also issued estimates for National Health Investors' Q2 2026 earnings at $1.21 EPS, Q3 2026 earnings at $1.22 EPS and Q4 2026 earnings at $1.23 EPS.
Separately, Truist Financial lifted their price target on National Health Investors from $70.00 to $76.00 and gave the stock a "hold" rating in a research report on Wednesday. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat, National Health Investors currently has an average rating of "Hold" and an average price target of $85.50.
Read Our Latest Report on National Health Investors
National Health Investors Stock Down 1.7 %
Shares of National Health Investors stock traded down $1.28 during trading on Tuesday, reaching $73.47. The company's stock had a trading volume of 712,093 shares, compared to its average volume of 203,269. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. The company has a market cap of $3.36 billion, a price-to-earnings ratio of 25.25, a P/E/G ratio of 4.42 and a beta of 1.08. National Health Investors has a 1-year low of $57.80 and a 1-year high of $86.13. The company has a 50-day simple moving average of $70.37 and a two-hundred day simple moving average of $74.62.
National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share for the quarter, topping analysts' consensus estimates of $1.10 by $0.03. The firm had revenue of $85.75 million during the quarter, compared to analysts' expectations of $81.13 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%.
National Health Investors Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, May 2nd. Shareholders of record on Monday, March 31st will be given a dividend of $0.90 per share. The ex-dividend date of this dividend is Monday, March 31st. This represents a $3.60 dividend on an annualized basis and a yield of 4.90%. National Health Investors's dividend payout ratio is currently 115.38%.
Institutional Trading of National Health Investors
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Norges Bank purchased a new position in shares of National Health Investors during the 4th quarter valued at about $42,322,000. Millennium Management LLC raised its stake in shares of National Health Investors by 1,967.0% during the 4th quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust's stock valued at $33,843,000 after buying an additional 464,727 shares during the last quarter. Balyasny Asset Management L.P. purchased a new position in shares of National Health Investors during the 4th quarter valued at about $23,917,000. Marshall Wace LLP raised its stake in shares of National Health Investors by 161.6% during the 4th quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust's stock valued at $38,225,000 after buying an additional 340,712 shares during the last quarter. Finally, Zimmer Partners LP purchased a new position in shares of National Health Investors during the 3rd quarter valued at about $25,218,000. Institutional investors and hedge funds own 62.51% of the company's stock.
National Health Investors Company Profile
(
Get Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Read More

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.